Powered by

aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring

Mar 11, 2019 - GlobeNewswire

Partnership to accelerate development of IND candidates from tRNA synthetases in aTyr's pipeline  

aTyr eligible to receive up to $17 million in potential option fees

SAN DIEGO, March 11, 2019 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it has entered into a research collaboration and option agreement with global biother...